11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)
Open accessAbstract
BACKGROUND: According to the latest revised National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (now known as the Alzheimer's Association) (NINCDS-ADRDA) diagnostic criteria for Alzheimer's disease dementia, the confidence in diagnosing mild cognitive impairment (MCI) due to Alzheimer's disease dementia is raised with the application of imaging biomarkers. These tests, added to core clinical criteria, might increase the sensitivity or specificity of a testing strategy. However, the accuracy of biomarkers in the diagnosis of Alzheimer's disease dementia and other dementias has not yet been systematically evaluated. A formal systematic evaluation of the sensitivity, specificity, and other properties of positron emission tomography (PET) imaging with the (11)C-labelled Pittsburgh Compound-B ((11)C-PIB) ligand was performed. OBJECTIVES: To determine the diagnostic accuracy of the (11)C- PIB-PET scan for detecting participants with MCI at baseline who will clinically convert to Alzheimer's disease dementia or other forms of dementia over a period of time. SEARCH METHODS: The most recent search for this review was performed on 12 January 2013. We searched MEDLINE (OvidSP), EMBASE (OvidSP), BIOSIS Previews (ISI Web of Knowledge), Web of Science and Conference Proceedings (ISI Web of Knowledge), PsycINFO (OvidSP), and LILACS (BIREME). We also requested a search of the Cochrane Register of Diagnostic Test Accuracy Studies (managed by the Cochrane Renal Group).No language or date restrictions were applied to the electronic searches and methodological filters were not used so as to maximise sensitivity. SELECTION CRITERIA: We selected studies that had prospectively defined cohorts with any accepted definition of MCI with baseline (11)C-PIB-PET scan. In addition, we only selected studies that applied a reference standard for Alzheimer's dementia diagnosis for example NINCDS-ADRDA or Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria. DATA COLLECTION AND ANALYSIS: We screened all titles generated by electronic database searches. Two review authors independently assessed the abstracts of all potentially relevant studies. The identified full papers were assessed for eligibility and data were extracted to create two by two tables. Two independent assessors performed quality assessment using the QUADAS 2 tool. We used the hierarchical summary receiver operating characteristic (ROC) model to produce a summary ROC curve. MAIN RESULTS: Conversion from MCI to Alzheimer's disease dementia was evaluated in nine studies. The quality of the evidence was limited. Of the 274 participants included in the meta-analysis, 112 developed Alzheimer's dementia. Based on the nine included studies, the median proportion converting was 34%. The studies varied markedly in how the PIB scans were done and interpreted.The sensitivities were between 83% and 100% while the specificities were between 46% and 88%. Because of the variation in thresholds and measures of (11)C-PIB amyloid retention, we did not calculate summary sensitivity and specificity. Although subject to considerable uncertainty, to illustrate the potential strengths and weaknesses of (11)C-PIB-PET scans we estimated from the fitted summary ROC curve that the sensitivity was 96% (95% confidence interval (CI) 87 to 99) at the included study median specificity of 58%. This equated to a positive likelihood ratio of 2.3 and a negative likelihood ratio of 0.07. Assuming a typical conversion rate of MCI to Alzheimer's dementia of 34%, for every 100 PIB scans one person with a negative scan would progress and 28 with a positive scan would not actually progress to Alzheimer's dementia.There were limited data for formal investigation of heterogeneity. We performed two sensitivity analyses to assess the influence of type of reference standard and the use of a pre-specified threshold. There was no effect on our findings. AUTHORS' CONCLUSIONS: Although the good sensitivity achieved in some included studies is promising for the value of (11)C-PIB-PET, given the heterogeneity in the conduct and interpretation of the test and the lack of defined thresholds for determination of test positivity, we cannot recommend its routine use in clinical practice.(11)C-PIB-PET biomarker is a high cost investigation, therefore it is important to clearly demonstrate its accuracy and standardise the process of the (11)C-PIB diagnostic modality prior to it being widely used.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Six currently available Cochrane reviews on CSF or amyloid PET biomarkers consistently concluded that routine use of these biomarkers in clinical practice cannot be recommended.
“Considering general medical practice and standard of care, the six currently available Cochrane reviews on the use of CSF or amyloid PET biomarkers have consistently led to the same conclusion: that the routine use of these biomarkers in clinical practice cannot be recommended.73–78”
From Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group (2021) · cites this paper as [73]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199 · see citing works
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · see citing works
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882 · see citing works
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155 · see citing works
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069 · see citing works
Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1546 · Cited by 5,047 · see citing works
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946 · see citing works
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921 · see citing works
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works
Weıntraub, S. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120075013 · Cited by 3,012 · see citing works
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992 · see citing works
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1304839 · Cited by 1,960 · see citing works
Cholinesterase inhibitors for Alzheimer's disease
Birks, J. S. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005593 · Cited by 1,906 · see citing works
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869 · see citing works
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659 · see citing works
A hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations
Rutter, C. M., & Gatsonis, C. (2001) · Statistics in Medicine · doi:10.1002/sim.942 · Cited by 1,510 · see citing works
Mild Cognitive Impairment: Ten Years Later
Petersen, R. C., Roberts, R. O., Knopman, D. S., Boeve, B. F., Geda, Y. E., Ivnik, R. J., Smith, G. E., & Jack, C. R. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.266 · Cited by 1,447 · see citing works
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331 · see citing works
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Mattsson, N. (2009) · JAMA · doi:10.1001/jama.2009.1064 · Cited by 1,176 · see citing works
McShane, R., Areosa Sastre, A., & Minakaran, N. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003154.pub5 · Cited by 1,155 · see citing works
Self-citationImaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104 · see citing works
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099 · see citing works
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Rowe, C. C., Ellis, K. A., Rimajova, M., Bourgeat, P., Pike, K. E., Jones, G., Fripp, J., Tochon-Danguy, H., Morandeau, L., O'Keefe, G., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.007 · Cited by 986 · see citing works
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958 · see citing works
The neuropathology of probable Alzheimer disease and mild cognitive impairment
Schneider, J. A., Arvanitakis, Z., Leurgans, S. E., & Bennett, D. A. (2009) · Annals of Neurology · doi:10.1002/ana.21706 · Cited by 935 · see citing works
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900 · see citing works
Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.noc60123 · Cited by 897 · see citing works
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
Villemagne, V. L., Pike, K. E., Chételat, G., Ellis, K. A., Mulligan, R. S., Bourgeat, P., Ackermann, U., Jones, G., Szoeke, C., Salvado, O., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22248 · Cited by 833 · see citing works
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780 · see citing works
PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 725 · see citing works
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
Price, J. C., Klunk, W. E., Lopresti, B. J., Lu, X., Hoge, J. A., Ziolko, S. K., Holt, D. P., MELTZER, C. C., DeKosky, S. T., & Mathis, C. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600146 · Cited by 712 · see citing works
Rinne, J. O., Brooks, D. J., Rossor, M. N., Fox, N. C., Bullock, R., Klunk, W. E., Mathis, C. A., Blennow, K., Barakos, J., Okello, A. A., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70043-0 · Cited by 701 · see citing works
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., Koeppe, R. A., Mathis, C. A., Weiner, M. W., Jagust, W. J., et al. (2009) · Brain · doi:10.1093/brain/awn320 · Cited by 684 · see citing works
Identification of normal and pathological aging in prospectively studied nondemented elderly humans
Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S.-H., & Aronson, M. K. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90027-u · Cited by 643 · see citing works
(2007) · YUHSpace (Yonsei University Medical Library) · doi:10.1016/s1474 · Cited by 641 · see citing works
Is MCI really just early dementia? A systematic review of conversion studies
Bruscoli, M., & Lovestone, S. (2004) · International Psychogeriatrics · doi:10.1017/s1041610204000092 · Cited by 550 · see citing works
Jack, C. R., Wiste, H. J., Vemuri, P., Weigand, S. D., Senjem, M. L., Zeng, G., Bernstein, M. A., Gunter, J. L., Pankratz, V. S., Aisen, P. S., et al. (2010) · Brain · doi:10.1093/brain/awq277 · Cited by 531 · see citing works
Conversion of amyloid positive and negative MCI to AD over 3 years
Okello, A., Koivunen, J., Edison, P., Archer, H. A., Turkheimer, F., Någren, K., Bullock, R. M., Walker, Z., Kennedy, A. M., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b23564 · Cited by 522 · see citing works
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Johnson, K. A., Gregas, M., Becker, J. A., Kinnecom, C., Salat, D. H., Moran, E. K., Smith, E. E., Rosand, J., Rentz, D. M., Klunk, W. E., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21164 · Cited by 495 · see citing works
Frontotemporal dementia: Clinicopathological correlations
Forman, M. S., Farmer, J., Johnson, J. K., Clark, C. M., Arnold, S. E., Coslett, H. B., Chatterjee, A., Hurtig, H. I., Karlawish, J. H., Rosen, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20873 · Cited by 478 · see citing works
11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Rabinovici, G. D., Furst, A. J., O’Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L., Chetty, S., Patel, P. R., Pagliaro, T. A., Klunk, W. E., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259035.98480.ed · Cited by 408 · see citing works
Evidence base of clinical diagnosis: Evaluation of diagnostic procedures
Knottnerus, J. A. (2002) · BMJ · doi:10.1136/bmj.324.7335.477 · Cited by 358 · see citing works
Leeflang, M., Moons, K. G. M., Reitsma, J. B., & Zwinderman, A. H. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.096032 · Cited by 351 · see citing works
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report.
Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augustinack, J. C., Johnson, K. A., Irizarry, M. C., Klunk, W. E., Mathis, C. A., DeKosky, S. T., et al. (2007) · PubMed · doi:10.1001/archneur.64.3.431 · Cited by 341 · see citing works
Amyloid imaging in mild cognitive impairment subtypes
Wolk, D. A., Price, J. C., Saxton, J. A., Snitz, B. E., James, J. A., López, O. L., Aizenstein, H. J., Cohen, A. D., Weissfeld, L. A., Mathis, C. A., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21598 · Cited by 339 · see citing works
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD
Rabinovici, G. D., Rosen, H. J., Alkalay, A., Kornak, J., Furst, A. J., Agarwal, N., Mormino, E. C., O'Neil, J. P., Janabi, M., Karydas, A., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31823b9c5e · Cited by 318 · see citing works
Villemagne, V. L., Pike, K. E., Darby, D., Maruff, P. T., Savage, G. R., Ng, S., Ackermann, U., Cowie, T., Currie, J. N., Chan, S. G., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.008 · Cited by 291 · see citing works
Newell, K. L., Hyman, B. T., Growdon, J. H., & Hedley-Whyte, E. T. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199911000-00004 · Cited by 289 · see citing works
Resnick, S. M., Sojkova, J., Zhou, Y., An, Y., Ye, W., Holt, D. P., Dannals, R. F., Mathis, C. A., Klunk, W. E., Ferrucci, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d3e3e9 · Cited by 288 · see citing works
Walhovd, K. B., Fjell, A. M., Brewer, J., McEvoy, L. K., Fennema-Notestine, C., Hagler, D. J., Jennings, R. G., Karow, D., Dale, A. M., & Initiative, T. A. D. N. (2010) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1809 · Cited by 279 · see citing works
Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain · doi:10.1093/brain/aws125 · Cited by 255 · see citing works
Matthews, F. E., Stephan, B. C. M., McKeith, I. G., Bond, J., & Brayne, C. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01820.x · Cited by 226 · see citing works
Ten-year risk of dementia in subjects with mild cognitive impairment
Visser, P. J., Kester, A. D. M., JOLLES, J., & Verhey, F. R. J. (2006) · Neurology · doi:10.1212/01.wnl.0000238517.59286.c5 · Cited by 217 · see citing works
In vivo amyloid imaging with PET in frontotemporal dementia
Engler, H., Santillo, A. F., Wang, S. X., Lindau, M. P., Savitcheva, I., Nordberg, A. K., Lannfelt, L., Långström, B., & Kilander, L. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0523-1 · Cited by 214 · see citing works
Leinonen, V. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.noc80013 · Cited by 199 · see citing works
Impact of molecular imaging on the diagnostic process in a memory clinic
Ossenkoppele, R., Prins, N. D., Pijnenburg, Y. A. L., Lemstra, A. W., van der Flier, W. M., Adriaanse, S. F., Windhorst, A. D., Handels, R. L. H., Wolfs, C. A. G., Aalten, P., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.07.003 · Cited by 194 · see citing works
Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
Koivunen, J., Scheinin, N., Virta, J. R., Aalto, S., Vahlberg, T., Någren, K., Helin, S., Parkkola, R., Viitanen, M., & Rinne, J. O. (2011) · Neurology · doi:10.1212/wnl.0b013e318212015e · Cited by 188 · see citing works
A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
Nordberg, A., Carter, S. F., Rinne, J., Drzezga, A., Brooks, D. J., Vandenberghe, R., Perani, D., Forsberg, A., Långström, B., Scheinin, N., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2237-2 · Cited by 186 · see citing works
Espinosa, A., Alegret, M., Valero, S., Vinyes‐Junque, G., Hernández, I., Mauleón, A., Rosende‐Roca, M., Ruiz, A., López, O. L., Tárraga, L., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122002 · Cited by 184 · see citing works
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia
Gomperts, S. N., Locascio, J. J., Rentz, D. M., Santarlasci, A., Marquié, M., Johnson, K. A., & Growdon, J. H. (2012) · Neurology · doi:10.1212/wnl.0b013e31827b1a07 · Cited by 182 · see citing works
Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI
Toledo, J. B., Vanderstichele, H., Figurski, M., Aisen, P. S. S., Petersen, R. C., Weiner, M. W., Jack, C. R., Jagust, W., DeCarli, C. S., Toga, A. W., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0861-8 · Cited by 177 · see citing works
Brain amyloid and cognition in Lewy body diseases
Gomperts, S. N., Locascio, J. J., Marquié, M., Santarlasci, A., Rentz, D. M., Maye, J. E., Johnson, K. A., & Growdon, J. H. (2012) · Movement Disorders · doi:10.1002/mds.25048 · Cited by 168 · see citing works
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
Ossenkoppele, R., Tolboom, N., Foster‐Dingley, J. C., Adriaanse, S. F., Boellaard, R., Yaqub, M. M., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2102-3 · Cited by 161 · see citing works
Mild Cognitive Impairment: An Operational Definition and Its Conversion Rate to Alzheimer’s Disease
Geslani, D. M., Tierney, M. C., Herrmann, N., & Szalai, J. P. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000084709 · Cited by 159 · see citing works
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease
Kadir, A., Almkvist, O., Forsberg, A., Wall, A. E., Engler, H., Långström, B., & Nordberg, A. K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.06.015 · Cited by 154 · see citing works
Amyloid imaging of Lewy body‐associated disorders
Foster, E. R., Campbell, M. C., Burack, M. A., Hartlein, J. M., Flores, H. P., Cairns, N. J., Hershey, T. G., & Perlmutter, J. S. (2010) · Movement Disorders · doi:10.1002/mds.23393 · Cited by 147 · see citing works
Hampel, H. J., Lista, S., & Khachaturian, Z. S. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2116 · Cited by 138 · see citing works
Trzepacz, P. T., Yu, P., Sun, J., Schuh, K. J., Case, M. G., Witte, M. M., Hochstetler, H. M., & Hake, A. M. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.06.018 · Cited by 129 · see citing works
Zhang, S., Han, D., Tan, X., Feng, J., Guo, Y., & Ding, Y. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02845.x · Cited by 121 · see citing works
Self-citationClinical Features of Frontotemporal Dementia
Boxer, A. L., & Miller, B. L. (2005) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000183086.99691.91 · Cited by 120 · see citing works
The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
Beckett, L. A., Harvey, D. J., Gamst, A. C., Donohue, M., Kornak, J., Zhang, H., Kuo, J. H., & Initiative, A. D. N. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.002 · Cited by 119 · see citing works
Quinn, T. J., Fearon, P. A., Noel-Storr, A. H., Young, C., McShane, R. H., & Stott, D. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010079.pub2 · Cited by 118 · see citing works
Self-citationSpatial patterns of brain amyloid- burden and atrophy rate associations in mild cognitive impairment
Tosun, D., Schuff, N. W., Mathis, C. A., Jagust, W., Weiner, M. W., & Initiative, A. D. N. (2011) · Brain · doi:10.1093/brain/awr044 · Cited by 117 · see citing works
Johnson, K. A., Minoshima, S., Bohnen, N. I., Donohoe, K. J., Foster, N. L., Herscovitch, P., Karlawish, J. H., Rowe, C. C., Hedrick, S., Pappas, V., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.06.001 · Cited by 108 · see citing works
Serrano‐Pozo, A., Qian, J., Monsell, S. E., Frosch, M. P., Betensky, R. A., & Hyman, B. T. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000016 · Cited by 105 · see citing works
Forsberg, A., Almkvist, O., Engler, H., Wall, A., Långström, B., & Nordberg, A. K. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274446 · Cited by 104 · see citing works
PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
Koivunen, J., Pirttilä, T., Kemppainen, N. M., Aalto, S., Herukka, S., Jauhianen, A. M., Hänninen, T., Hallikainen, M., Någren, K., Rinne, J. O., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000163927 · Cited by 101 · see citing works
Longitudinal Patterns of β-Amyloid Deposition in Nondemented Older Adults
Sojkova, J., Zhou, Y., An, Y., Kraut, M. A., Ferrucci, L., Wong, D. F., & Resnick, S. M. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.77 · Cited by 99 · see citing works
Ewers, M., Insel, P. A., Jagust, W. J., Shaw, L. M. J., Trojanowski, J. Q., Aisen, P. S. S., Petersen, R. C., Schuff, N. W., Weiner, M. W., & Initiative, A. D. N. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr271 · Cited by 96 · see citing works
Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease
Blennow, K., Hampel, H. J., & Zetterberg, H. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.154 · Cited by 79 · see citing works
Shin, J., Lee, S., Kim, S. J., Kim, S., Cho, S., & Kim, Y.-B. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.013 · Cited by 76 · see citing works
Ellis, K., Rowe, C., Villemagne, V., Martins, R., Masters, C., Salvado, O., Szoeke, C., & Ames, D. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.009 · Cited by 76 · see citing works
Specific estrogen sulfotransferase (SULT1E1) substrates and molecular imaging probe candidates
Cole, G. B., Keum, G., Liu, J., Small, G. W., Satyamurthy, N., Kepe, V., & Barrio, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914904107 · Cited by 73 · see citing works
Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
Holland, D., McEvoy, L. K., Desikan, R. S., Dale, A. M., & Initiative, A. D. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047739 · Cited by 70 · see citing works
Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?
Sojkova, J., Beason‐Held, L. L., Zhou, Y., An, Y., Kraut, M. A., Ye, W., Ferrucci, L., Mathis, C. A., Klunk, W. E., Wong, D. F., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051946 · Cited by 70 · see citing works
β‐amyloid in lewy body disease is related to Alzheimer's disease‐like atrophy
Shimada, H., Shinotoh, H., Hirano, S., Miyoshi, M., Sato, K., Tanaka, N., Ota, T., Fukushi, K., Irie, T., Ito, H., et al. (2012) · Movement Disorders · doi:10.1002/mds.25286 · Cited by 65 · see citing works
Grimmer, T., Wutz, C., Drzezga, A. E., Förster, S., Förstl, H., Ortner, M., Perneczky, R., & Kurz, A. (2013) · Current Alzheimer Research · doi:10.2174/1567205011310010011 · Cited by 43 · see citing works
Five-year follow-up of 11C-PIB uptake in Alzheimer’s disease and MCI
Kemppainen, N. M., Scheinin, N. M., Koivunen, J., Johansson, J. J., Toivonen, J., Någren, K., Rokka, J., Karrasch, M., Parkkola, R. K., & Rinne, J. O. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2562-0 · Cited by 38 · see citing works
Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals
Driscoll, I. F., Zhou, Y., An, Y., Sojkova, J., Davatzikos, C. A., Kraut, M. A., Ye, W., Ferrucci, L., Mathis, C. A., Klunk, W. E., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.008 · Cited by 37 · see citing works
Multimodal Imaging of Alzheimer Pathophysiology in the Brain′s Default Mode Network
Shin, J., Kepe, V., Small, G. W., Phelps, M. E., & Barrio, J. R. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/687945 · Cited by 31 · see citing works
Researchers Test Strategies to Prevent Alzheimer Disease
Friedrich, M. J. (2014) · JAMA · doi:10.1001/jama.2014.3891 · Cited by 24 · see citing works
P ittsburgh compound B retention and progression of cognitive status – a meta‐analysis
Chen, X., Li, M., Wang, S., Zhu, H., Xiong, Y., & Liu, X. (2014) · European Journal of Neurology · doi:10.1111/ene.12398 · Cited by 22 · see citing works
Does a Positive Pittsburgh Compound B Scan in a Patient With Dementia Equal Alzheimer Disease?
Ducharme, S., Guiot, M., Nikelski, J., & Chertkow, H. M. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.420 · Cited by 22 · see citing works
Cognitive Decline and Amyloid Accumulation in Patients with Mild Cognitive Impairment
Koivunen, J., Karrasch, M., Scheinin, N. M., Aalto, S., Vahlberg, T. J., Någren, K., Helin, S., Viitanen, M. H., & Rinne, J. O. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000341580 · Cited by 21 · see citing works
Assessing Mild Cognitive Impairment with Amyloid and Dopamine Terminal Molecular Imaging
Albin, R. L., Burke, J. F., Koeppe, R. A., Giordani, B., Gilman, S., & Frey, K. A. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.112599 · Cited by 20 · see citing works
Banzo, I., Jiménez-Bonilla, J. F., Ortega-Nava, F., Quirce, R., Martínez‐Rodríguez, I., de Arcocha-Torres, M., Rodríguez‐Rodríguez, E., Vázquez, J. L., Sánchez, P. J., Martínez‐Amador, N., et al. (2013) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000042 · Cited by 20 · see citing works
Grimmer, T., Wutz, C., Drzezga, A. E., et al. (2013) · Current Alzheimer Research · doi:10.2174/156720513804871499 · Cited by 20 · see citing works
Drzezga, A. E. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0697-6 · Cited by 17 · see citing works
Royall, D. R., & Palmer, R. F. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131733 · Cited by 11 · see citing works
Shinotoh, H., Shimada, H., Hirano, S., Tanaka, N., Sato, K., Kiyoshi, F., Irie, T., Eguchi, Y., Ito, H., & Suhara, T. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.628 · Cited by 5 · see citing works
P1‐386: Predicting brain amyloid‐β burden with atrophy in MCI
Tosun, D., Schuff, N. W., Weiner, M. W., & Initiative, A. D. N. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.667 · Cited by 3 · see citing works
Ishii, K., Sakata, M., Oda, K., Toyohara, J., Ishiwata, K., Senda, M., Ito, K., Kuwano, R., Iwatsubo, T., Initiative, T. J. A. D. N., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.659 · Cited by 3 · see citing works
Ellis, K. A., Rowe, C. C., Masters, C. L., Szoeke, C. E. I., Taddei, K., Martins, R. N., Villemagne, V. L., Fahey, M. T., Ames, D. J., Maruff, P. T., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.426 · Cited by 3 · see citing works
Burns, L. C., Berman, R., Guo, Z., Soares, H. D., Kaplita, S., Yoo, B., & Donohue, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.579 · Cited by 2 · see citing works
Villemagne, V. L., Ellis, K. A., Chételat, G., Bourgeat, P., Jones, G. R., Martins, R. N., Salvado, O., Ames, D. J., Masters, C. L., & Rowe, C. C. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.142 · Cited by 2 · see citing works
Maruff, P. T., Ellis, K. A., Harrington, K., Gale, J., Fredrickson, A., Darby, D., & Masters, C. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.724 · Cited by 2 · see citing works
Mosconi, L., Matthews, D. C., Schmidt, M. E., & Andrews, R. D. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.935 · Cited by 2 · see citing works
IC‐P‐049: Change in amyloid deposition is related to concurrent cognitive change in MCI
Landau, S. M., Petersen, R. C., Aisen, P. S. S., & Jagust, W. J. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.118 · Cited by 2 · see citing works
P1‐341: Amyloid deposition in non‐demented elderly predicts longitudinal cognitive decline
Rentz, D. M., Betensky, R. A., Becker, J. A., Amariglio, R. E., Maye, J. E., Gidicsin, C. M., Sperling, R. A., & Johnson, K. A. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.621 · Cited by 2 · see citing works
Okello, A., Edison, P., Archer, H. A., Hinz, R., Fox, N. C., Rossor, M. N., & Brooks, D. J. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.958 · Cited by 2 · see citing works
Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G. R., Ellis, K. A., Ames, D. J., Martins, R. N., Head, R. J., Salvado, O., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.636 · Cited by 1 · see citing works
Perrotin, A., Desgranges, B., Duval, C., Joie, R. L., Mézenge, F., Landeau, B., Pèlerin, A., Sayette, V. D. L., Barré, L., Eustache, F., et al. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.185 · Cited by 1 · see citing works
Flagged first, then by citations
Research works printed but not linked: 17
- Forsberg A, Engler H, Blomquist G, Almkvist O, Hagman G, Wall A, et al. PET imaging of amyloid depositions in MCI patients using PIB. Journal of Cerebral Blood Flow and Metabolism 2007; Vol. 27 Suppl 1:BO03‐01.
- Riddle WR, Shokouhi S, Donlevy SC. Monitoring brain changes in mild cognitive impairment and a biomarker for structural changes and correlations with serial PET‐FDG scans, PET‐PIB scans, and MMSE scores. European Journal of Neurology 2012; Vol. 19 Suppl 1:110.
- Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 2013;40(1):104‐14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nordberg A, Carter SF, Rinne J, Drzezga A, Brooks DJ, Vandenberghe R, et al. A European multicentre PET study of fibrillar amyloid in Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 2013; Vol. 40, issue 1:104‐14. [DOI] [PMC free article] [PubMed]
- Choo H, Lee DY, Seo EH, Kim YK, Yoon EJ, Lee DS, et al. PIB retention changes in cognitively normal, mild cognitive impairment and Alzheimer's disease: One year follow‐up study IL [Conference: Alzheimer's Association International Conference, AAIC 11 Paris France. Conference Start: 20110716 Conference End: 20110721. Conference Publication: (var.pagings)]. Alzheimer's & Dementia 2011; Vol. 7, issue 4 Suppl 1:S208‐9.
- Kadir A, Alkmvist O, Forsberg A, Wall A, Engler H, Langstrom B at al. Dynamic changes in PET amyloid and FDG imaging at diffetrent stages of Alzheimer's disease. Neurobiology of Aging 2012;33:198.e1‐198.e14. [DOI] [PubMed] [Google Scholar]
- Dekosky ST, Mathis CA, Price JC, Lopresti BJ, Meltzer CC, Ziolko SK, et al. Human amyloid‐imaging studies with Pittsburgh compound‐B in mild cognitive impairment (MCI): Is MCI the critical period of amyloid plaque deposition?. Neurology 2006; Vol. 66, issue 5:A60.
- Bossuyt PM, Leeflang MM. Chapter 6: Developing criteria for including studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.4 2008.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd revised edition. Washington, DC: American Psychiatric Association 1987.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: American Psychiatric Association 1994.
- Hatashita S, Yamasaki H. PET biomarkers of beta‐amyloid deposition and neuronal injury in mild cognitive impairment due to Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging 2012; Vol. 39:S407.
- Knotnerus A, Weel C, Muris JWM. Evaluation of diagnostic procedures. BMJ 2002;324:477‐80. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, et al. Beta‐amyloid peptides enhance alpha‐synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proceedings of the National Academy of the Sciences of the United States of America 2001;98(21):12245‐50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McKhann GM, Knopman DS, Chertkow H, Hyman BT, Clifford RJ, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendation from the National Institute on Ageing and Alzheimer’s Association workgroup. Alzheimer’s & Dementia 2011; Vol. 7, issue 3:263‐9. [DOI] [PMC free article] [PubMed]
- SAS Institute Inc. 2011. SAS/OR® 9.3 User’s Guide: Mathematical Programming. Cary, NC: SAS Institute Inc. SAS/OR® 9.3 User’s Guide: Mathematical Programming Copyright © 2011. SAS Institute Inc., Cary, NC, USA http://support.sas.com/documentation/cdl/en/ormpug/63975/PDF/default/ormpug.pdf (access 18 January 2013) . [Google Scholar]
- Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, et al. Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology 2009;65(5):557‐68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- World Health Organization. Mental Health. Alzheimer’s Disease. http:// www.afro.who.int/mentalhealth/related_disease/alyheimer_disease.html. Last updated 18 September 2002 (archives, accessed 4 March 2004). [Google Scholar]
Cited by
Sorted by citations
Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group
Dubois, B., Villain, N., Frisoni, G. B., Rabinovici, G. D., Sabbagh, M., Cappa, S., Bejanin, A., Bombois, S., Epelbaum, S., Teichmann, M., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00066-1 · Cited by 1,051 · see citing works
Arévalo-Rodríguez, I., Smailagic, N., Figuls, M. R. I., Ciapponi, A., Sanchez-Perez, E., Giannakou, A., Pedraza, O. L., Bonfill, X., & Cullum, S. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010783.pub2 · Cited by 897 · see citing works
Self-citationArévalo-Rodríguez, I., Smailagic, N., Figuls, M. R. I., Ciapponi, A., Sanchez-Perez, E., Giannakou, A., Pedraza, O. L., Bonfill, X., & Cullum, S. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010783.pub3 · Cited by 491 · see citing works
Self-citationMultimodal imaging in Alzheimer's disease: validity and usefulness for early detection
Teipel, S. J., Drzezga, A. E., Grothe, M. J., Barthel, H., Chételat, G., Schuff, N. W., Skudlarski, P., Cavedo, E., Frisoni, G. B., Hoffmann, W. U., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00093-9 · Cited by 263 · see citing works
Morris, E., Chalkidou, A., Hammers, A., Peacock, J. L., Summers, J. A., & Keevil, S. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3228-x · Cited by 249 · see citing works
Weissberger, G. H., Strong, J. V., Stefanidis, K. B., Summers, M. J., Bondi, M. W., & Stricker, N. H. (2017) · Neuropsychology Review · doi:10.1007/s11065-017-9360-6 · Cited by 152 · see citing works
Epidemiology of Dementia: The Burden on Society, the Challenges for Research
Wolters, F. J., & Ikram, M. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7704-8_1 · Cited by 88 · see citing works
Fantoni, E. R., Chalkidou, A., O’ Brien, J. T., Farrar, G., & Hammers, A. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171093 · Cited by 68 · see citing works
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
Bogolepova, A. N., Васенина, Е. Е., Gomzyakova, N. A., Gusev, E. I., Dudchenko, N. G., Emelin, А. Y., Zalutskaya, N. M., Isaev, R. I., Kotovskaya, Y. V., Levin, O. S., et al. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20211211036 · Cited by 72 · see citing works
Bradshaw, N. J., & Korth, C. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0133-2 · Cited by 64 · see citing works
PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
Wang, J., Jin, C., Zhou, J., Zhou, R., Tian, M., Lee, H. J., & Zhang, H. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05999-z · Cited by 66 · see citing works
Martínez, G., Vernooij, R. W. M., Padilla, P. F., Zamora, J., Bonfill, X., & Flicker, L. A. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012216.pub2 · Cited by 59 · see citing works
An Algorithm for Preclinical Diagnosis of Alzheimer's Disease
Khan, T. K. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00275 · Cited by 55 · see citing works
Martínez, G., Vernooij, R. W. M., Padilla, P. F., Zamora, J., Flicker, L. A., & Bonfill, X. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012884 · Cited by 55 · see citing works
Fluorescence Chemicals To Detect Insoluble and Soluble Amyloid-β Aggregates
Lee, D.-H., Kim, S., Kim, H. Y., & Kim, Y. S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00199 · Cited by 54 · see citing works
Pusil, S. A., Dimitriadis, S. I., López, M. E., Pereda, E., & Maestú, F. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101972 · Cited by 50 · see citing works
Matías‐Guiu, J. A., Cabrera‐Martín, M. N., Moreno‐Ramos, T., Valles‐Salgado, M., Fernández‐Matarrubia, M., Carreras, J. L., & Matías‐Guiu, J. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7738-z · Cited by 47 · see citing works
Martínez, G., Vernooij, R. W. M., Padilla, P. F., Zamora, J., Flicker, L. A., & Bonfill, X. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012883 · Cited by 42 · see citing works
Li, Q., Wu, X., Xu, L., Chen, K., Yao, L., & Initiative, A. D. N. (2018) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2017.00117 · Cited by 38 · see citing works
CSF p-tau/Aβ42 ratio and brain FDG-PET may reliably detect MCI “imminent” converters to AD
Santangelo, R., Masserini, F., Agosta, F., Sala, A., Caminiti, S. P., Cecchetti, G., Caso, F., Martinelli, V., Pinto, P., Passerini, G., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04853-4 · Cited by 37 · see citing works
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
Ogonowski, N. S., Salcidua, S., León, T., Chamorro-Veloso, N., Valls, C., Avalos, C., Bisquertt, A., Rentería, M. E., Orellana, P., & Duran-Aniotz, C. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.807764 · Cited by 32 · see citing works
Poutiainen, P., Jaronen, M., Quintana, F. J., & Brownell, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00085 · Cited by 31 · see citing works
Hagberg, G., Ihle‐Hansen, H., Fure, B., Thommessen, B., Ihle‐Hansen, H., Øksengård, A. R., Beyer, M. K., Wyller, T. B., Müller, E. G., Pendlebury, S. T., et al. (2020) · BMC Neurology · doi:10.1186/s12883-020-01753-w · Cited by 30 · see citing works
Clinical imaging in dementia with Lewy bodies
Surendranathan, A., & O’Brien, J. T. (2018) · Evidence Based Mental Health · doi:10.1136/eb-2017-102848 · Cited by 27 · see citing works
Prognostic plasma protein panel for Aβ deposition in the brain in Alzheimer’s disease
Park, J., Han, S.-H., Lee, H., Jeong, H., Byun, M. S., Bae, J., Kim, H., Lee, D. Y., Yi, D., Shin, S. A., et al. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101690 · Cited by 27 · see citing works
Rostamzadeh, A., & Jessen, F. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-00907-y · Cited by 25 · see citing works
Venazzi, A., Swardfager, W., Lam, B., Siqueira, J. D. O., Herrmann, N., & Cogo‐Moreira, H. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00221 · Cited by 21 · see citing works
Shaikh, T. A., & Ali, R. (2021) · International Journal of Information Technology · doi:10.1007/s41870-020-00606-6 · Cited by 20 · see citing works
RetractedDown Syndrome, Obesity, Alzheimer’s Disease, and Cancer: A Brief Review and Hypothesis
Nixon, D. W. (2018) · Brain Sciences · doi:10.3390/brainsci8040053 · Cited by 19 · see citing works
Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer’s disease
Alexopoulos, P., Gleixner, L. S., Werle, L., Buhl, F., Thierjung, N., Giourou, E., Kagerbauer, S. M., Gourzis, P., Kübler, H. R., Grimmer, T., et al. (2017) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-017-0815-9 · Cited by 18 · see citing works
Amyloid solutions: lecanemab, gantenerumab, and donanemab in the treatment of Alzheimer's disease
Ameen, T. B., Ali, U., Salma, O., Samee, M. A., Abbas, S. M. I., Kashif, S. N., Arifi, M. A., Ali, M., Khowaja, M., Ali, S. M. S., et al. (2025) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-025-00968-3 · Cited by 17 · see citing works
Chen, P., Hsu, H., Chao, Y., Nouchi, R., Wang, P., & Cheng, C. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13691 · Cited by 14 · see citing works
Zhao, Q. X., Du, X., Chen, W., Zhang, T., & Xu, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1216215 · Cited by 13 · see citing works
Mesa-Herrera, F., Marín, R., Torrealba, E., Santos, G., & Díaz, M. L. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.879146 · Cited by 13 · see citing works
Evidence-based indications for the planning of PET or PET/CT capacities are needed
Fuchs, S., Grössmann, N., Ferch, M., Busse, R., & Wild, C. (2019) · Clinical and Translational Imaging · doi:10.1007/s40336-019-00314-7 · Cited by 12 · see citing works
Weidman, D. A., ZAMRINI, E. Y., Sabbagh, M. N., Jacobson, S. A., Burke, A. D., Belden, C. M., Powell, J. J., Bhalla, N., Roontiva, A., Kuang, X., et al. (2017) · Neurocase · doi:10.1080/13554794.2017.1290806 · Cited by 11 · see citing works
The clinical value of fluid biomarkers for dementia diagnosis
Dyer, S. M., Flicker, L. A., Laver, K., Whitehead, C., & Cumming, R. G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30238-1 · Cited by 10 · see citing works
Two decades of [11C]PiB synthesis, 2003-2023: a review
Myburgh, P. J. (2024) · American Journal of Nuclear Medicine and Molecular Imaging · doi:10.62347/adsk6584 · Cited by 9 · see citing works
Friends and Foes in Alzheimer’s Disease
Pauwels, E. K. J., & Boer, G. J. (2023) · Medical Principles and Practice · doi:10.1159/000534400 · Cited by 9 · see citing works
Faldu, K. G., & Shah, J. (2022) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2022.2104639 · Cited by 9 · see citing works
Teipel, S. J., Dyrba, M., Vergallo, A., Lista, S., Habert, M. O., Potier, M., Lamari, F., Dubois, B., Hampel, H. J., & Grothe, M. J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.748198 · Cited by 7 · see citing works
Functional cognitive disorder: Beyond pseudodementia
Marín‐Medina, D. S., Arenas-Vargas, P. A., Velásquez-Duque, M. D. P., & Bagnati, P. (2024) · Neurology Perspectives · doi:10.1016/j.neurop.2024.100179 · Cited by 6 · see citing works
Martínez, G., Flicker, L. A., Vernooij, R. W. M., Padilla, P. F., Zamora, J., Figuls, M. R. I., Urrútia, G., & Bonfill, X. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012216 · Cited by 6 · see citing works
Case of Autosomal Dominant Alzheimer Disease With Negative Findings From PiB-PET Examination
Sun, H., Wang, Y., Wang, Y., & Zeng, F. (2023) · Neurology Genetics · doi:10.1212/nxg.0000000000200119 · Cited by 5 · see citing works
Serdyuk, O., Sidenkova, A. P., & Хилюк, Д. А. (2021) · Psikhiatriya · doi:10.30629/2618-6667-2021-19-2-17-28 · Cited by 4 · see citing works
Rueda, A., & Luis Fernando Enríquez, S. (2018) · Biosalud · doi:10.17151/biosa.2018.17.2.5 · Cited by 6 · see citing works
Lauretani, F., Ruffini, L., Testa, C., Salvi, M., Scarlattei, M., Baldari, G., Zucchini, I., Lorenzi, B., Cattabiani, C., & Maggio, M. G. (2021) · Geriatrics · doi:10.3390/geriatrics6040110 · Cited by 3 · see citing works
The Turning Point for Alzheimer’s
de la Torre, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34057-9_16 · Cited by 2 · see citing works
Lazli, L., Boukadoum, M., & Mohamed, O. A. (2017) · International Conference on Image Processing Theory, Tools and Applications (IPTA) · doi:10.1109/ipta.2017.8310095 · Cited by 2 · see citing works
Pinto, J. O., Peixoto, B., Dores, A. R., & Barbosa, F. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16070363 · Cited by 1 · see citing works
de la Torre, J. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34057-9_7 · Cited by 1 · see citing works
Jellinger, K. A. (2015) · EMJ Neurology · doi:10.33590/emjneurol/10311025 · Cited by 1 · see citing works
Low filler volume concentration composite dielectrics
Gilbert, L. J. (2006) · PhDT
Larner, A. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-16697-1_4
Nordberg, A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00071-3
Developing a PET normal brain template using diffusion tensor imaging images: A proof of concept
Wongsa, P., Sungkarat, W., & Auethavekiat, S. (2023) · Journal of Associated Medical Sciences · doi:10.12982/jams.2023.031
Noninfectious Disease Vaccines
Speiser, D. E., El-Turabi, A., & Bachmann, M. F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00042-6
Wang, L., Zheng, Z., Su, Y., Chen, K., Weidman, D., Wu, T., Lo, S., Lure, F. Y. M., Li, J., Initiative, A. D. N., et al. (2023) · IISE Transactions on Healthcare Systems Engineering · doi:10.1080/24725579.2023.2249487
Neurodegenerative und Demenzielle Erkrankungen
Teipel, S. J., Kurth, J., Prudlo, J., Mohnike, W., & Krause, B. J. (2024) · Springer eBooks · doi:10.1007/978-3-662-67192-4_29
Copolímero-1 como terapia potencial para el deterioro cognitivo leve
Fuentes-Fernández-Cueto, M., & Ibarra, A. (2023) · Neurología, Neurocirugía y Psiquiatría · doi:10.35366/115406
Demenzdiagnose mittels Biomarker – geht das?
Teipel, S. J. (2025) · neuroreha · doi:10.1055/a-2515-5986
Chaudhary, U. (2025) · Springer eBooks · doi:10.1007/978-3-031-78991-5_6
(2022) · Elsevier eBooks · doi:10.1016/b978-3-437-21884-2.00033-7
Kilimann, I., & Teipel, S. J. (2022) · Elsevier eBooks · doi:10.1016/b978-3-437-21884-2.00014-3
Pathophysiological Insights and Therapeutic Approaches of Oxidative Stress in Alzheimer’s Disease
Karati, D., Garai, T., Sen, S., Mukherjee, S., Jha, S. K., & Debnath, B. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010008
Lista, S., Filippi, L., Emanuele, E., López-Ortiz, S., Cisale, G. Y., Minoretti, P., Garaci, F., & Santos-Lozano, A. (2026) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-026-00879-w
Surhan, A., Oad, J., Kumar, B., Memon, S. N., Essrani, C., Muhammad, F., Kashif, S. N., Abbas, S. M. I., Ameen, T. B., Sauleh, A., et al. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01263-5
- Authors
- Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., & Feng, J.
- Affiliations
- Sheng Jing Hospital (CN)
- University of Cambridge (GB)
- University of Exeter (GB)
- John Radcliffe Hospital (GB)
- University of Birmingham (GB)
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2014-07-23
- Volume
- 2014
- Issue
- 7
- Pages
- CD010386-CD010386
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6464750
- OpenAlex
- W4210951082
- Cited by
- 66
- References
- 116
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 3 · 2023: 7 · 2022: 6 · 2021: 8 · 2020: 3 · 2019: 4 · 2018: 8 · 2017: 7 · 2016: 5 · 2015: 7
- FWCI
- 0.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- National Institute for Health and Care Research (10/4001/05)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- 11C-PiB PET, Pittsburgh compound B, Alzheimer's dementia, mild cognitive impairment, conversion to dementia, diagnostic accuracy, positron emission tomography, imaging biomarkers, amyloid imaging, sensitivity and specificity, NINCDS-ADRDA criteria, DSM-IV diagnostic criteria, dementia diagnosis, early diagnosis of dementia, QUADAS
- MeSH terms
- Aged, Alzheimer Disease, Aniline Compounds, Carbon Radioisotopes, Dementia, Humans, Prospective Studies, Sensitivity and Specificity, Thiazoles, Disease Progression, Early Diagnosis, Positron-Emission Tomography, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
